HECW2
Basic information
Region (hg38): 2:196189099-196593684
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with hypotonia, seizures, and absent language (Definitive), mode of inheritance: AD
- neurodevelopmental disorder with hypotonia, seizures, and absent language (Strong), mode of inheritance: AD
- neurodevelopmental disorder with hypotonia, seizures, and absent language (Strong), mode of inheritance: AD
- complex neurodevelopmental disorder (Definitive), mode of inheritance: AD
- complex neurodevelopmental disorder (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with hypotonia, seizures, and absent language | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic | 27334371; 27389779 |
ClinVar
This is a list of variants' phenotypes submitted to
- Neurodevelopmental disorder with hypotonia, seizures, and absent language (4 variants)
- HECW2-related disorder (2 variants)
- Inborn genetic diseases (2 variants)
- Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies (1 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HECW2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 37 | 15 | 55 | |||
missense | 25 | 151 | 49 | 10 | 239 | |
nonsense | 6 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 7 | 2 | 10 | ||
non coding | 9 | |||||
Total | 4 | 25 | 166 | 89 | 32 |
Variants in HECW2
This is a list of pathogenic ClinVar variants found in the HECW2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-196201240-C-A | Neurodevelopmental disorder with hypotonia, seizures, and absent language | Benign (Aug 10, 2021) | ||
2-196201282-C-T | Inborn genetic diseases | Likely pathogenic (Sep 08, 2017) | ||
2-196201290-A-G | Neurodevelopmental disorder with hypotonia, seizures, and absent language | Uncertain significance (Nov 08, 2019) | ||
2-196201349-G-A | Likely benign (Jul 01, 2023) | |||
2-196201354-G-A | Neurodevelopmental disorder with hypotonia, seizures, and absent language | Conflicting classifications of pathogenicity (Sep 01, 2022) | ||
2-196201379-T-A | Benign (Sep 01, 2023) | |||
2-196201386-G-A | Likely benign (May 01, 2024) | |||
2-196215912-T-G | Likely benign (Apr 01, 2023) | |||
2-196215918-G-A | HECW2-related disorder | Benign/Likely benign (Jul 01, 2024) | ||
2-196215922-C-T | Neurodevelopmental disorder with hypotonia, seizures, and absent language | Uncertain significance (Feb 05, 2020) | ||
2-196215958-C-G | Inborn genetic diseases | Pathogenic/Likely pathogenic (Nov 21, 2023) | ||
2-196215961-G-T | Neurodevelopmental disorder with hypotonia, seizures, and absent language | Likely pathogenic (Mar 17, 2021) | ||
2-196215962-A-C | Neurodevelopmental disorder with hypotonia, seizures, and absent language | Likely pathogenic (Oct 19, 2020) | ||
2-196215965-T-C | Neurodevelopmental disorder with hypotonia, seizures, and absent language | Likely pathogenic (Mar 17, 2021) | ||
2-196217017-C-A | Inborn genetic diseases | Likely pathogenic (Jun 07, 2016) | ||
2-196217025-G-A | Developmental disorder | Uncertain significance (Nov 19, 2021) | ||
2-196217031-C-G | Neurodevelopmental disorder with hypotonia, seizures, and absent language | Likely pathogenic (Jul 03, 2018) | ||
2-196217042-C-A | Inborn genetic diseases | Uncertain significance (Jun 16, 2024) | ||
2-196217055-C-T | Inborn genetic diseases | Uncertain significance (Sep 29, 2023) | ||
2-196217066-C-T | Neurodevelopmental disorder with hypotonia, seizures, and absent language | Conflicting classifications of pathogenicity (May 20, 2023) | ||
2-196217067-G-A | Likely benign (Feb 01, 2024) | |||
2-196220033-T-C | Inborn genetic diseases | Uncertain significance (Mar 27, 2024) | ||
2-196220088-T-G | Likely benign (Jun 06, 2018) | |||
2-196220089-G-A | Uncertain significance (Oct 24, 2017) | |||
2-196220092-C-A | Neurodevelopmental disorder with hypotonia, seizures, and absent language | Likely pathogenic (Mar 17, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HECW2 | protein_coding | protein_coding | ENST00000260983 | 28 | 399323 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000299 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.31 | 625 | 905 | 0.691 | 0.0000523 | 10311 |
Missense in Polyphen | 149 | 346.65 | 0.42983 | 3824 | ||
Synonymous | 0.777 | 323 | 341 | 0.947 | 0.0000202 | 3074 |
Loss of Function | 6.98 | 13 | 80.6 | 0.161 | 0.00000475 | 865 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000174 | 0.000174 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000106 | 0.000105 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000143 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination of TP73. Acts to stabilize TP73 and enhance activation of transcription by TP73 (PubMed:12890487). Involved in the regulation of mitotic metaphase/anaphase transition (PubMed:24163370). {ECO:0000269|PubMed:12890487, ECO:0000269|PubMed:24163370}.;
- Disease
- DISEASE: Neurodevelopmental disorder with hypotonia, seizures, and absent language (NDHSAL) [MIM:617268]: A neurodevelopmental disorder characterized by severely delayed psychomotor development, absent speech, epilepsy, encephalopathy, hypotonia, dystonia/dyskinesia, and macrocephaly. Brain imaging show cerebral atrophy, enlarged ventricles, and white matter abnormalities. {ECO:0000269|PubMed:27389779}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
(Consensus)
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- rvis_EVS
- -2.47
- rvis_percentile_EVS
- 0.98
Haploinsufficiency Scores
- pHI
- 0.461
- hipred
- Y
- hipred_score
- 0.563
- ghis
- 0.528
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.795
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hecw2
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- protein polyubiquitination;ubiquitin-dependent protein catabolic process;protein ubiquitination;regulation of mitotic metaphase/anaphase transition;proteasome-mediated ubiquitin-dependent protein catabolic process;positive regulation of protein catabolic process;regulation of dendrite morphogenesis;negative regulation of sodium ion transmembrane transporter activity
- Cellular component
- cytoplasm;mitotic spindle
- Molecular function
- protein binding;ubiquitin protein ligase activity